Table 1.
Cotswold Modification of the Ann Arbor Staging for HL
Stage | Description |
---|---|
I | Involvement of a single lymph node region or lymphoid structure |
II | Involvement of ≥ two lymph node regions on the same side of the diaphragm |
III | Involvement of lymph node regions on both sides of the diaphragm |
III1 With or without involvement of splenic, hilar, celiac, or portal nodes | |
III2 With involvement of para-aortic, iliac, and mesenteric nodes | |
IV | Diffuse or disseminated involvement of one or more extranodal organs or tissues, with or without associated lymph node involvement |
A | No symptoms |
B | Fever (temperature, >38°C [100.4°F]), drenching night sweats, unexplained loss of >10% of body weight within the preceding 6 months |
X | Bulky disease (a widening of the mediastinum by more than one-third due to presence of a nodal mass with a maximal dimension greater than 10 cm) |
E | Involvement of a single extranodal site that is contiguous or proximal to the known nodal site |
CS | Clinical stage |
PS | Pathologic stage |